Notably, the NOP56–FBL interaction or their involvement in ribosome biogenesis-related oncogenic pathways has also been observed in other malignancies, such as colorectal cancer and breast cancer, suggesting that this regulatory axis may represent a more universal cancer-promoting mechanism rather than one restricted to HCC (42). This evidence concerns the gene NOP56 and colorectal cancer.